Zhejiang Shengda Pharm (603079.SS) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China · ISIN CNE100002W43
Zhejiang Shengda Pharm financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 827.40 m CNY | 844.54 m CNY |
| Gross profit | 163.60 m CNY | 220.87 m CNY |
| Operating income | 46.57 m CNY | 84.49 m CNY |
| EBIT | 51.38 m CNY | 81.04 m CNY |
| Net income | 29.42 m CNY | 62.16 m CNY |
| Diluted EPS – continuing operations | 0.17 CNY | 0.33 CNY |
Full history since 2012, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Zhejiang Shengda Pharm
Zhejiang Shengda Bio-Pharm Co., Ltd. engages in the developing, producing, and selling of food and feed additives in China and internationally. The company offers vitamins, such as biotin and folic acid; biopreservatives and functional ingredients, including nisin, natamycin, polylysine, and sucrose fermentation products; and intermediate APIs. It serves pharmaceutical, nutritional, food, and animal feed industries. The company was incorporated in 1999 and is headquartered in Tiantai, China.
More stocks
- Dimerco Express (5609.TWO)
- Hibiscus Petroleum BHD (5199.KL)
- ALPHA (0303.KL)
- Public Policy Holding Company, Inc. (PPHC)
- FS Bancorp, Inc. (FSBW)
- Coveo Solutions Inc (CVO.TO)
- Shenke Slide Bearing Corp (002633.SZ)
- Tonnellerie Francois Freres SA (TFF.PA)
- Zhejiang Dayang Biotech Group Co (003017.SZ)
- Perfect Group Corp Ltd Class A (603059.SS)
- PERMA FIX ENVIRONMENTAL SERVICES INC (PESI)
- Cooper-Standard Holdings Inc. (CPS)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.